The OXY-VENT Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 515 participants.

Also called NCT07870551

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 515 participants (planned count) (from the registry)
Sponsor
Jeroen van Eijk (from the registry)
Registry
  • NCT NCT07870551
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07870551. Randomized; double masking; primary purpose treatment. Start 2027-01-01 (anticipated); primary completion 2028-06-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The OXY-VENT Study
Acronym
OXY-VENT
Condition
Cardiac Arrest (CA)
Intervention (Device)
Ventilation Feedback Device (Active)
Intervention (Device)
Control (Recording-Only)
Lead sponsor
Jeroen van Eijk (class: other)
Collaborator
Archeon Medical (class: not stated)

Record details

Record id
cardio:ct-nct07870551
Content hash
b17d3ad265eeab6e62ea5557ee671b0c65739667ba2ef27b1e2c4ca11ea1f97a